Fig 1.
Flowchart of the study sample selection from the NHIRD in Taiwan.
MM: ICD-9-CM 203.0. Inclusion criteria: MM. Exclusion criteria: gender unknown.
Fig 2.
KM test for cumulative OS in four-year tracking among patients with MM aged 18 and above treated with bortezomib (NHIRD analysis).
Table 1.
Characteristics of patients with MM treated with bortezomib in the NHIRD analysis.
Fig 3.
Factors of mortality in four-year tracking among patients with MM stratified by bortezomib treatment and BMT (NHIRD analysis).
Table 2.
Mortality factors in four-year tracking among patients with MM treated with bortezomib using Cox regression (NHIRD analysis).
Table 3.
Characteristics of patients with MM treated with bortezomib at a single institute (TSGH).
Fig 4.
KM test for PFS of bone marrow transplantation in the first-line bortezomib group (TSGH analysis).
Fig 5.
KM test for cumulative OS in the first-line and non-first-line bortezomib group (TSGH analysis).